CLINICAL TRIALS PROFILE FOR NICLOSAMIDE
✉ Email this page to a colleague
All Clinical Trials for Niclosamide
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00138359 ↗ | Mass Treatment T Solium Community Study | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | N/A | 2004-12-01 | Investigators from Cayetano Heredia University and Johns Hopkins University are doing this study. They want to see how people and pigs get infected with a parasite, called cysticercus (known as "pig triquina"). Cysticercus attacks the meat of pigs and the brains of people. In the intestine, the parasite is known as "solitaria". This study is to see how treatment in both people and pigs works to control the disease. |
| NCT01296958 ↗ | Targeted Screening for Taenia Solium Tapeworms | Completed | National Institute of Neurological Disorders and Stroke (NINDS) | N/A | 2011-05-01 | The purpose of this study is to determine whether screening and treatment of tapeworm carriers can decrease community transmission of Taenia solium parasitic infection. |
| NCT01296958 ↗ | Targeted Screening for Taenia Solium Tapeworms | Completed | National University of San Marcos, Peru | N/A | 2011-05-01 | The purpose of this study is to determine whether screening and treatment of tapeworm carriers can decrease community transmission of Taenia solium parasitic infection. |
| NCT01296958 ↗ | Targeted Screening for Taenia Solium Tapeworms | Completed | Universidad Nacional Mayor de San Marcos | N/A | 2011-05-01 | The purpose of this study is to determine whether screening and treatment of tapeworm carriers can decrease community transmission of Taenia solium parasitic infection. |
| NCT01296958 ↗ | Targeted Screening for Taenia Solium Tapeworms | Completed | Oregon Health and Science University | N/A | 2011-05-01 | The purpose of this study is to determine whether screening and treatment of tapeworm carriers can decrease community transmission of Taenia solium parasitic infection. |
| NCT02519582 ↗ | Drug Trial to Investigate the Safety and Efficacy of Niclosamide Tablets in Patients With Metastases of a Colorectal Cancer Progressing After Therapy | Unknown status | Center for Molecular Medicine | Phase 2 | 2015-08-01 | Phase II trial evaluating the safety and efficacy of oral appliqued niclosamide in patients who are progressive with metachronous or synchronous metastases of colorectal cancer among the previous therapy (Nikolo). Monocentric open-label clinical trial of phase II. All patients received 2 g p.o. niclosamide daily until progression (according to RECIST) or unacceptable toxicity or discontinuation of study for other reasons. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Niclosamide
Condition Name
Clinical Trial Locations for Niclosamide
Trials by Country
Clinical Trial Progress for Niclosamide
Clinical Trial Phase
Clinical Trial Sponsors for Niclosamide
Sponsor Name
